Skip to main content

Table 1 Baseline participant characteristics in total participants and subgroups stratified by baseline systolic blood pressure level

From: Lack of a bridge between screening and medical management for hypertension: health screening cohort in Japan

Variables

Total

Baseline systolic blood pressure

N = 153,523

< 140 mmHg n = 132,653

140–159 mmHg n = 16,720

≥160 mmHg n = 4150

Age, years

49.8 (8.3)

49.2 (8.1)

53.0 (8.8)

54.5 (8.6)

BMI, kg/m2

23.3 (3.6)

23.0 (3.5)

24.9 (3.9)

25.3 (4.3)

HbA1c, %

5.6 (0.6)

5.5 (0.6)

5.7 (0.8)

5.8 (1.1)

Systolic blood pressure, mmHg

122.6 (16.7)

118.0 (12.0)

147.1 (5.5)

171.3 (11.6)

Diastolic blood pressure, mmHg

75.9 (12.0)

73.3 (9.9)

90.4 (8.9)

101.2 (11.9)

LDL cholesterol, mg/dL

127.2 (32.2)

126.6 (31.9)

131.0 (33.9)

132.6 (35.4)

  

n (%)

n (%)

n (%)

Men

99,474 (64.8)

83,287 (62.8)

12,972 (77.6)

3215 (77.5)

Current smoking

45,280 (29.5)

37,955 (28.6)

5744 (34.4)

1581 (38.1)

Drinking alcohol: Not everyday

89,877 (67.4)

79,862 (69.0)

8094 (57.5)

1921 (54.9)

Drinking alcohol: Everyday, small amount

30,537 (22.9)

25,752 (22.3)

3822 (27.1)

963 (27.5)

Drinking alcohol: Everyday, large amount

12,895 (9.7)

10,113 (8.7)

2167 (15.4)

615 (17.6)

Diagnosed comorbidities

 Diabetes

3015 (2.0)

2474 (1.9)

445 (2.7)

96 (2.3)

 Cancer

2845 (1.9)

2493 (1.9)

295 (1.8)

57 (1.4)

 Chronic lung disease

7879 (5.1)

7059 (5.3)

701 (4.2)

119 (2.9)

 Liver disease

6092 (4.0)

5238 (4.0)

716 (4.3)

138 (3.3)

 Peptic ulcer

6119 (4.0)

5356 (4.0)

654 (3.9)

109 (2.6)

 Cerebrovascular disease

1677 (1.1)

1476 (1.1)

172 (1.0)

29 (0.7)

 Peripheral vascular disease

1737 (1.1)

1521 (1.2)

181 (1.1)

35 (0.8)

 Insomnia

5492 (3.6)

4974 (3.8)

455 (2.7)

63 (1.5)

 Depression

3093 (2.0)

2851 (2.2)

217 (1.3)

25 (0.6)

  1. Abbreviations: M mean, SD standard deviation, BMI body mass index